Company intelligence / Profile preview

Pharmako Biotechnologies

Frenchs Forest, New South Wales, Australiapharmako.com.au ↗

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

Pharmako Biotechnologies has developed multiple award-winning advanced delivery systems that have been clinically validated in over 30 human pharmacokinetic and clinical trials. Their platforms significantly improve the bioavailability and absorption of poorly soluble or fat-soluble active ingredients used in supplements. Over 20 papers have been published in high-impact journals validating their approaches.

Therapeutic areas: Other
Modalities: Nanoparticle (e.g., liposomal technology)Powdered oil conversion (CPO®)Micro-crystalline surface coating (LipiSperse®)
Industry: Non-Drug Biotech

Partnerships

Gencor Pacific (“strategic partner” providing distribution/customization)

Beyond the preview

Go deeper on Pharmako Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmako Biotechnologies.

Explore the full profile